3.8 Article

Should tobacco and alcohol companies be allowed to influence Australia's National Drug Strategy?

期刊

PUBLIC HEALTH RESEARCH & PRACTICE
卷 27, 期 2, 页码 -

出版社

SAX INST
DOI: 10.17061/phrp2721714

关键词

-

资金

  1. National Cancer Institute, US National Institutes of Health, Grant [R01-CA091021]

向作者/读者索取更多资源

Formation of Australia's National Drug Strategy (NDS) included an extensive consultation process that was open not only to community and public health stakeholders, but also to representatives of the tobacco and alcohol industries. Australia is bound by the World Health Organization Framework Convention on Tobacco Control, which requires governments to protect tobacco control measures from interference by the tobacco industry. NDS consultation submissions made by these conflicted industries are not publicly available for scrutiny. The NDS goals are at odds with the commercial agenda of industries that support regulatory stagnation, oppose and undermine effective action, ignore and distort evidence, and prioritise profits over health.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据